What is NDC 14789-135?

14789-135 is the product NDC for Tacrolimus, Tacrolimus 5 mg/mL injection, listed with the FDA by Nexus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Nexus Pharmaceuticals, LLC, NDC labeler code 14789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tacrolimus?

93 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tacrolimus NDC 14789-135 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)14789-135Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14789-0135Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14789-135-05	1478901350514789013505	10 VIAL in 1 CARTON (14789-135-05) / 1 mL in 1 VIAL (14789-135-07)Marketed from Dec 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tacrolimus
Generic name (nonproprietary): tacrolimus
Active ingredients: Tacrolimus — 5 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Nexus Pharmaceuticals, LLCNDC labeler code 14789
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217108
Marketing start: Dec 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Calcineurin Inhibitors (Mechanism)
Identifiers: Product ID 14789-135_44fc0987-ff9d-3099-e063-6394a90a7a55SPL ID 44fc0987-ff9d-3099-e063-6394a90a7a55SPL set ID 9d502961-e9c0-4611-92bf-ce742a7b962cRxCUI 198379UNII WM0HAQ4WNMUPC 0314789135052
Pharmacologic class: Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414789013505 followed by a unit qualifier and the quantity

Package 14789-0135-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 2, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Tacrolimus is a is a calcineurin-inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in adult patients receiving allogeneic liver, kidney or heart transplants, and pediatric patients receiving allogeneic liver transplants in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver or Heart Transplant Tacrolimus is indicated for the prophylaxis of organ rejection, in adult patients receiving allogeneic kidney transplant [see Clinical Studies ( 14.1 )], liver transplants [see Clinical Studies ( 14.2 )] and heart transplant [see Clinical Studies ( 14.3 )], and pediatric patients receiving allogeneic liver transplants [see Cl…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 14789-135

What is NDC 14789-135?: 14789-135 is the product NDC for Tacrolimus, Tacrolimus 5 mg/mL injection, listed with the FDA by Nexus Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tacrolimus.
What is the active ingredient?: Tacrolimus.
Who is the labeler?: Nexus Pharmaceuticals, LLC, NDC labeler code 14789. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tacrolimus?: 93 other product NDCs are listed under this name. See all Tacrolimus NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tacrolimus NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tacrolimus	Tacrolimus .5 mg/1	CapsuleOral	AvPAK	50268-736	50268-0736-15
Tacrolimus	Tacrolimus 1 mg/1	CapsuleOral	AvPAK	50268-737	50268-0737-15
Tacrolimus	Tacrolimus .5 mg/1	CapsuleOral	Safecor Health LLC	48433-092	48433-0092-20
Tacrolimus	Tacrolimus 1 mg/1	CapsuleOral	Safecor Health LLC	48433-093	48433-0093-20
Tacrolimus	Tacrolimus 5 mg/1	CapsuleOral	Safecor Health LLC	48433-094	48433-0094-20
Tacrolimus	Tacrolimus .5 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2780	69238-2780-03
Tacrolimus	Tacrolimus 1 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2781	69238-2781-03
Tacrolimus	Tacrolimus 5 mg/1	Capsule, Extended releaseOral	Amneal Pharmaceuticals NY LLC	69238-2782	69238-2782-03
Tacrolimus	Tacrolimus .5 mg/1	CapsuleOral	Stellon Biotech Inc.	85972-101	85972-0101-0185972-0101-30
Tacrolimus	Tacrolimus 1 mg/1	CapsuleOral	Stellon Biotech Inc.	85972-102	85972-0102-0185972-0102-30

All 94 Tacrolimus NDCs